小方制药(603207.SH)：委托博济医药技术开发中药1.1类新药“复方侧柏酊”（脱发适应症）

Core Viewpoint - The company has signed a contract with Boji Pharmaceutical Technology Co., Ltd. to assist in the clinical research and registration of a new traditional Chinese medicine product, Compound Cypra, aiming to complete clinical trials and market launch [1] Group 1 - The company is engaged in the development of traditional Chinese medicine [1] - The collaboration with Boji Pharmaceutical is expected to enhance the company's capabilities in clinical research [1] - The focus is on the clinical trial and registration process for a Class 1 new drug [1]